Provided by Tiger Trade Technology Pte. Ltd.

CureVac B.V.

5.48
+0.20003.79%
Post-market: 5.48-0.0012-0.02%19:23 EST
Volume:5.05M
Turnover:27.40M
Market Cap:1.23B
PE:5.85
High:5.49
Open:5.29
Low:5.26
Close:5.28
52wk High:5.72
52wk Low:2.48
Shares:225.17M
Float Shares:125.87M
Volume Ratio:3.89
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9365
EPS(LYR):0.7483
ROE:16.43%
ROA:11.72%
PB:1.22
PE(LYR):7.32

Loading ...

BioNTech Says CureVac Shareholders Are Advised To Tender Their Shares By 6:00 P.M. Eastern Time On Tuesday, December 2, 2025

Reuters
·
Yesterday

BioNTech shares update on exchange offer for CureVac shares

TIPRANKS
·
Yesterday

CureVac NV Held Extraordinary General Meeting

Reuters
·
Yesterday

Nasdaq Surges 350 Points; Enlivex Therapeutics Shares Spike Higher

Benzinga
·
Nov 24

CureVac Q3 EPS $1.41 Beats $(0.17) Estimate, Sales $63.295M Beat $14.520M Estimate

Benzinga
·
Nov 24

Update: CureVac Q3 Earnings, Revenue Fall; German Regulators Clear BioNTech Acquisition

MT Newswires Live
·
Nov 24

CureVac reports Q3 EPS EUR 1.21 vs. EUR 1.51 last year

TIPRANKS
·
Nov 24

Earnings Flash (CVAC) CureVac Posts Q3 EPS 1.21 Euros

MT Newswires Live
·
Nov 24

BioNTech Offer for CureVac Shares Enters Final Phase After Regulatory Clearance

Reuters
·
Nov 24

Curevac Reaffirms Its Expected Cash Runway Into 2028

Reuters
·
Nov 24

CureVac NV reports Q3 net profit of €273.2 million and nine-month net profit of €161.6 million

Reuters
·
Nov 24

CureVac Nv - Company Reaffirms Its Expected Cash Runway Into 2028

THOMSON REUTERS
·
Nov 24

CureVac Nv - Net Financial Result for Three and Nine Months Ended September 30, 2025, Was Loss of EUR 2.6 Mln and Gain of EUR 2.2 Mln, Respectively

THOMSON REUTERS
·
Nov 24

CureVac Nv - German Federal Cartel Office Clears BioNTech-CureVac Deal

THOMSON REUTERS
·
Nov 24

Does CureVac’s 108% Rally Signal a Smarter Opportunity After mRNA Breakthrough News?

Simply Wall St.
·
Nov 16

CureVac NV Announces Date for Extraordinary General Meeting

Reuters
·
Oct 24

BioNTech Launches Public Exchange Offer for All CureVac Shares

Reuters
·
Oct 22

BioNTech Receives Approval to Fully Acquire CureVac, Says German Antitrust Authority

Reuters
·
Oct 14

German Federal Cartel Office Approves Acquisition Of Curevac By Biontech

Reuters
·
Oct 14

CureVac's Q2 Pre-Tax Loss Narrows, Revenue Falls

MT Newswires Live
·
Aug 15